1-7 of 7
Maggie J. Allen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comprehensive Profiling of Clinical JAK2 Inhibitors in Myeloproliferative Neoplasms

Tim Kong, LaYow Yu, Angelo BA Laranjeira, Fan He, Maggie J. Allen, Stephen T Oh
Journal: Blood
Blood (2022) 140 (Supplement 1): 3951–3952.
https://doi.org/10.1182/blood-2022-164925
Published: 2022
Journal Articles

Transcriptional and Metabolic Profiling Reveals Alpha-Ketoglutarate As a Novel Mediator of Aberrant Platelet Activity and Inflammation in Myeloproliferative Neoplasms

Fan He, Angelo BA Laranjeira, Tim Kong, Katrina Bark, Alice Liu, Maggie J. Allen, Daniel AC Fisher, Mary Fulbright, LaYow Yu, Nina M. Lasky, Stephen M. Sykes, Angelo D'Alessandro, Jorge Di Paola, Stephen T Oh
Journal: Blood
Blood (2022) 140 (Supplement 1): 1095–1097.
https://doi.org/10.1182/blood-2022-167786
Published: 2022
Journal Articles

Targeting RSK1-Mediated Dependency and Inflammation in Myeloid Malignancies

Tim Kong, Angelo BA Laranjeira, LaYow Yu, Jared S. Fowles, Fan He, Maggie J. Allen, Stephen T Oh
Journal: Blood
Blood (2022) 140 (Supplement 1): 6724–6725.
https://doi.org/10.1182/blood-2022-164912
Published: 2022
Journal Articles

DUSP6 Mediates Resistance to JAK2 Inhibition and Drives Myeloproliferative Neoplasm Disease Progression

Tim Kong, Angelo BA Laranjeira, Kangning Yang, Daniel AC Fisher, LaYow Yu, Anthony Z Wang, Marianna B. Ruzinova, Jared S. Fowles, Maggie J. Allen, Hamza Celik, Grant A. Challen, Sidong Huang, Stephen T. Oh
Journal: Blood
Blood (2021) 138 (Supplement 1): 55.
https://doi.org/10.1182/blood-2021-147455
Published: 2021
Journal Articles

A Novel Humanized Animal Model Reveals Clonal Architecture and Therapeutic Vulnerabilities in Myelofibrosis

Hamza Celik, PhD, Ethan Krug, Hassan Bjeije, PhD, Nancy Issa, MD, Wentao Han, Won Kyun Koh, Ruochao CZ Zhang, PhD, Maggie J. Allen, Terrence N Wong, MD PhD, Daniel AC Fisher, PhD, Tiandao Li, Stephen T. Oh, MD PhD, Grant A. Challen, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-143034
Published: 2020
Journal Articles

Aberrant Cytokine Production in Myelofibrosis Is Not Rectified By Ruxolitinib and Is Differentially Sensitive to Inhibition of JAK/STAT, MAP Kinase, and NFκB Signaling

Daniel A.C. Fisher, PhD, Cathrine Miner, Elizabeth Engle, PhD, Hengrui Hu, Taylor B. Collins, Amy Zhou, MD, Maggie J. Allen, Olga Malkova, Stephen T Oh, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3062.
https://doi.org/10.1182/blood-2018-99-119022
Published: 2018
Journal Articles

Hepcidin Is Elevated in Primary and Secondary Myelofibrosis and Correlates with IL-6 and IL-2Rα but Is High in Patients Treated with Ruxolitinib

Amy Zhou, MD, Maggie J. Allen, Mary Fulbright, Jared S Fowles, PhD, Daniel A.C. Fisher, PhD, Stephen T Oh, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1760.
https://doi.org/10.1182/blood-2018-99-113661
Published: 2018